Study uncovers consequences of molnupiravir use to treat COVID-19
A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
Apr 8, 2024
0
45
A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
Apr 8, 2024
0
45
It's one of the most contagious viral diseases in the world—and outbreaks are popping up across the United States. More than 60 measles cases have been reported so far this year in 17 states, from Washington to Florida; ...
Apr 4, 2024
0
13
New research being presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) finds that pneumonia-causing bacteria are common in the over 60s ...
Apr 3, 2024
0
1
Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there's limited clinical experience. Nevertheless, successfully identifying ...
Apr 3, 2024
0
0
As we age, the immune system's efficacy weakens, leading to less effective defenses against new pathogens—such as the SARS-CoV-2 virus. How immunosenescence in older adults affects their immune response to COVID-19 mRNA ...
Apr 3, 2024
0
0
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective ...
Apr 2, 2024
0
27
Research led by the University of Sheffield found that dental patients at high risk of infective endocarditis, a life-threatening infection, should be given antibiotics before undergoing invasive dental treatment.
Apr 2, 2024
0
20
New research to be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27–30 April) details the case of a man who had received two doses of the mpox vaccine ...
Apr 1, 2024
0
0
A population-wide observational study to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows an association between tuberculosis ...
Mar 31, 2024
0
1
New real-world research being presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27–30 April), reveals that people living with multiple sclerosis ...
Mar 28, 2024
0
34